The company-led K quarantine and punishment-oriented distance has been strengthened by the appointment of Professor Moran Kim, a vaccine avoider, to the Blue House quarantine planning officer.
The proposition of “separating the distance between citizens,” which is essential in K quarantine, is expected to extend the treatment-led quarantine of the Blue House's domestic biotechnology company in the meantime.
Prof. Ki's appearance, who has continued to avoid vaccine avoidance, is interpreted as a supplement to the strategy of ‘vaccine avoidance’ and ‘creating a corona-free country with mild treatments this spring’ of Celltrion Chairman Seo Jeong-jin, who maintained the lead in corona prevention last year.
Prof. Ki opened the door for the transition to'distance from camps' through forced enforcement of distance based on the quarantine law focused on criminal punishment without compensation.
Prof. Ki provided a ‘social distancing’ policy shift from the Ebola quarantine in 2009 at the beginning of last year to the WHO's distancing campaign before the vaccine was developed as the chairman of the countermeasures for the early coronavirus field.
In the script, on February 28, 2020, Deputy Head of Headquarters Kwon Jun-wook announced'social isolation (distance)', and on June 28, the cost of distance was borne by the public as the policy of'implementing social distancing steps 1-3' as a policy. .
Professor Ki's team announced'corona simulation' on April 10 last year, and when social distancing is stopped, the spread rate increases by 50% from mid-February, and the number of confirmed cases is about 13,000 people, one month after two weeks. If there is a sudden increase of 43,000 people, the experiment by distancing quarantine was not mentioned. On June 23, last year, Professor Jae-gap Lee (Hallym University) said, “After the second pandemic, there have been channels for infectious disease experts to communicate. Communication with the public has been cut off," he said at MBC Radio, saying, "The opinions of infectious disease experts are not well communicated in the reprinted version or the script."
At a regular briefing on September 8 last year, Deputy Head of Kwon announced the production operation of Celltrion, saying, "Currently, the Ministry of Food and Drug Safety is reviewing phases 2 and 3 of the antibody treatment clinical trial plan, and plans to mass-produce commercial antibody treatments in September." By saying, "I expect that the safe and effective corona 19 vaccine will be secured as much as possible before Chuseok next year, so that the complete vaccination will be done calmly," revealing'expectation to distribute vaccines in one year' and securing'distance and treatment-oriented quarantine' again. did.
Professor Jae-wook Choi (Korea University) said to the'Defense Prevention Advisory Committee', "Every time, the list is secretly held, and the list is not disclosed. What kind of advisory meeting is that?" I speak with confidence,” he told JoongAng Ilbo on the 17th.
Professor Ki criticized an infectious disease expert at the time of the 3rd controversy and said, "Is this likely to appear after the short and short 3rd level upgrade?" That's not it. Even if they did their own modeling, the decline was slow.” He objected, and did not reveal the model that was not upgraded.
Professor Ki said, “The primary goal of vaccination is to reduce the number of deaths and to secure room in the intensive care unit. Therefore, it is the primary goal to meet the medical staff over 65 years of age, and this is the same for all other countries. Intensive medical support was announced.
The use of corona vaccine, which was excluded from the company-led K quarantine'test→trace→treat', was announced by Chairman Seo Jeong-jin of Celltrion on December 25 last year,'Early administration of treatments after early determination of the former national diagnostic test'. On the 20th, the Korean National Assembly requested amendment of the Pharmaceutical Affairs Act. Preventing and solving the shortage of beds' was announced as a quarantine policy.
Chairman Seo said to the Hankyoreh, “What we need right now is a cure, but Celltrion will supply a sufficient amount. Vaccines must be introduced from abroad, but unlike therapeutics, the global production will be sufficient, so don't worry. You can buy it if you have money. Celltrion can produce a vaccine if you only want to,” and raised the stock of Celltrion.
On December 23, last year, Sohn Young-rae, head of the Strategic Planning Team (Spokesman of the Ministry of Welfare) said, “The situation that the world's first vaccine was hit is a situation that should be avoided. It is very fortunate,” he said. “In the case of Korea, vaccinations will start focusing on high-risk targets as quickly as possible as soon as safety is confirmed by thoroughly preparing in advance for the vaccine license, vaccination process, and distribution process. Will”.
Celltrion's stocks soared four times compared to February in the early coronavirus, so Chairman Seo became the No. 1 stock in Korea, and the Blue House focused on bio (pharmaceutical) and led the K quarantine and the V-shaped rebound in the stock market.